Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.

Isaacson SH, Espay AJ, Pahwa R, Agarwal P, Shill HA, Hui J, Dashtipour K, Lew M, Qin P, Formella AE, Ceresoli-Borroni G, LeWitt PA, InfusON Study Group

Open source

DOI: 10.1177/1877718x241310727
Published: 2025 Mar
Container: Journal of Parkinson's disease
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1877718x241310727,
  title = {Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.},
  author = {Isaacson SH and Espay AJ and Pahwa R and Agarwal P and Shill HA and Hui J and Dashtipour K and Lew M and Qin P and Formella AE and Ceresoli-Borroni G and LeWitt PA and InfusON Study Group},
  year = {2025},
  journal = {Journal of Parkinson's disease},
  doi = {10.1177/1877718x241310727},
  url = {https://doi.org/10.1177/1877718x241310727}
}

RIS

TY  - JOUR
TI  - Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.
AU  - Isaacson SH
AU  - Espay AJ
AU  - Pahwa R
AU  - Agarwal P
AU  - Shill HA
AU  - Hui J
AU  - Dashtipour K
AU  - Lew M
AU  - Qin P
AU  - Formella AE
AU  - Ceresoli-Borroni G
AU  - LeWitt PA
AU  - InfusON Study Group
PY  - 2025
JO  - Journal of Parkinson's disease
DO  - 10.1177/1877718x241310727
UR  - https://doi.org/10.1177/1877718x241310727
ER  -

APA

SH, I., AJ, E., R, P., P, A., HA, S., J, H., K, D., M, L., P, Q., AE, F., G, C., PA, L., & Group, I. S. (2025). Continuous, subcutaneous apomorphine infusion for Parkinson disease motor fluctuations: Results from the phase 3, long-term, open-label United States InfusON study.. Journal of Parkinson's disease. https://doi.org/10.1177/1877718x241310727

Source records

pubmed · retrieved 2026-09-27T15:12:51.656Z
europe-pmc · retrieved 2026-09-27T15:12:51.676Z
doaj · retrieved 2026-09-27T15:12:51.656Z